Skip to content

Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Cough in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Study

Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Cough in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075932
Enrollment
Unknown
Registered
2023-09-20
Start date
2022-08-02
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cough in Lung Cancer

Interventions

TEAS group :Bilateral Feishu (BL 23), Pishu (BL 23), Shenshu (BL 23), Lieque (BL 4), Hegu (BL 4), and Taixi (BL 6) were selected for acupuncture. Transcutaneous electrical acupoint stimulation was adm
Sham TEAS group:The electrode patches were positioned identically as in the TEAS group, but the device wasn't activated, with each session lasting 30 minutes.

Sponsors

Yantai Affiliated Hospital of Binzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Elective thoracic surgery patients for lung cancer under VATS, aged between 18-75, who voluntarily signed an informed consent form. (2) Clinical or pathological diagnosis of NSCLC preoperatively with surgical indications. (3) American Society of Anesthesiologists (ASA) classification I-III. (4) No preoperative respiratory infections, history of chronic cough or sputum, acid reflux history, or post-nasal drip syndrome. (5) Surgery encompassing wedge resection of the lung, segmentectomy, or lobectomy.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications or adverse reactions to TEAS. (2) Refusal of postoperative follow-up by the patient or their families. (3) Poor comprehension or compliance. (4) Embedded electronic devices like pacemakers. (5) Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Cough VAS score;Leicester Cough Questionnaire;Incidence of Cough;C-reactive protein;IL-6;TNF-a;

Secondary

MeasureTime frame
Time of first flatus;Time of first defecation ;Time to first out of bed activity;Duration of chest drainage;Length of postoperative stay;Incidence of postoperative nausea and vomiting;Occurrence of adverse events;

Countries

China

Contacts

Public ContactShushan Jia

Yantai Affiliated Hospital of Binzhou Medical University

jiashushan@163.com+86 133 0649 9099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026